End-of-day quote
Shanghai S.E.
18:00:00 2024-04-28 EDT
|
5-day change
|
1st Jan Change
|
15.41
CNY
|
+0.33%
|
|
+0.78%
|
-9.46%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
23,252
|
22,302
|
23,778
|
15,988
|
25,427
|
22,933
|
-
|
-
|
Enterprise Value (EV)
1 |
29,451
|
23,121
|
23,086
|
14,968
|
23,635
|
20,074
|
19,155
|
18,230
|
P/E ratio
|
23.4
x
|
19.7
x
|
10.1
x
|
-63.3
x
|
23.6
x
|
19.6
x
|
16.2
x
|
15.4
x
|
Yield
|
2.14%
|
2.23%
|
2.08%
|
3.07%
|
1.94%
|
2.2%
|
2.3%
|
2.48%
|
Capitalization / Revenue
|
1.22
x
|
1.64
x
|
2.99
x
|
1.86
x
|
2.93
x
|
2.53
x
|
2.3
x
|
2.27
x
|
EV / Revenue
|
1.55
x
|
1.7
x
|
2.9
x
|
1.74
x
|
2.72
x
|
2.21
x
|
1.92
x
|
1.8
x
|
EV / EBITDA
|
16.7
x
|
11.2
x
|
7.32
x
|
50.8
x
|
14.2
x
|
9
x
|
8
x
|
7.69
x
|
EV / FCF
|
-
|
16,649,673
x
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
0%
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.1
x
|
1.87
x
|
1.83
x
|
1.3
x
|
2.06
x
|
1.74
x
|
1.61
x
|
1.5
x
|
Nbr of stocks (in thousands)
|
1,507,920
|
1,507,920
|
1,500,163
|
1,485,873
|
1,493,950
|
1,488,200
|
-
|
-
|
Reference price
2 |
15.42
|
14.79
|
15.85
|
10.76
|
17.02
|
15.41
|
15.41
|
15.41
|
Announcement Date
|
20-04-25
|
21-04-23
|
22-03-30
|
23-03-27
|
24-04-15
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
18,998
|
13,576
|
7,952
|
8,593
|
8,674
|
9,073
|
9,962
|
10,113
|
EBITDA
1 |
1,762
|
2,062
|
3,153
|
294.6
|
1,663
|
2,230
|
2,395
|
2,370
|
EBIT
1 |
1,338
|
1,472
|
2,733
|
-153
|
1,228
|
1,408
|
1,605
|
1,663
|
Operating Margin
|
7.04%
|
10.85%
|
34.37%
|
-1.78%
|
14.16%
|
15.52%
|
16.11%
|
16.44%
|
Earnings before Tax (EBT)
1 |
1,331
|
1,457
|
2,724
|
-160.5
|
1,221
|
1,409
|
1,715
|
1,808
|
Net income
1 |
1,001
|
1,126
|
2,359
|
-256.5
|
1,071
|
1,174
|
1,438
|
1,492
|
Net margin
|
5.27%
|
8.29%
|
29.66%
|
-2.99%
|
12.35%
|
12.94%
|
14.44%
|
14.76%
|
EPS
2 |
0.6600
|
0.7500
|
1.570
|
-0.1700
|
0.7200
|
0.7850
|
0.9520
|
0.9977
|
Free Cash Flow
|
-
|
1,389
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
10.23%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
67.33%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
123.34%
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.3300
|
0.3300
|
0.3300
|
0.3300
|
0.3300
|
0.3389
|
0.3545
|
0.3822
|
Announcement Date
|
20-04-25
|
21-04-23
|
22-03-30
|
23-03-27
|
24-04-15
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2,103
|
2,049
|
2,541
|
2,471
|
2,896
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
0.5800
|
-0.3719
|
0.1000
|
0.0500
|
0.0500
|
0.1774
|
0.2900
|
0.2200
|
0.0300
|
0.1976
|
-
|
-
|
-
|
0.2800
|
0.2700
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22-03-30
|
22-04-25
|
22-08-19
|
22-10-25
|
23-03-27
|
23-04-24
|
23-08-25
|
23-10-27
|
24-04-15
|
24-04-25
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
6,199
|
818
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
692
|
1,020
|
1,792
|
2,859
|
3,778
|
4,703
|
Leverage (Debt/EBITDA)
|
3.518
x
|
0.3968
x
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
1,389
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
9.28%
|
9.76%
|
18.4%
|
-2.04%
|
8.75%
|
8.84%
|
10.2%
|
9.97%
|
ROA (Net income/ Total Assets)
|
4.07%
|
5.56%
|
14.3%
|
-
|
-
|
6.6%
|
7.46%
|
7.55%
|
Assets
1 |
24,593
|
20,253
|
16,518
|
-
|
-
|
17,788
|
19,286
|
19,768
|
Book Value Per Share
2 |
7.360
|
7.910
|
8.660
|
8.270
|
8.250
|
8.870
|
9.570
|
10.30
|
Cash Flow per Share
2 |
1.110
|
1.180
|
1.870
|
1.520
|
1.720
|
1.130
|
1.090
|
1.440
|
Capex
1 |
729
|
403
|
503
|
402
|
668
|
494
|
383
|
365
|
Capex / Sales
|
3.84%
|
2.96%
|
6.32%
|
4.68%
|
7.7%
|
5.44%
|
3.85%
|
3.61%
|
Announcement Date
|
20-04-25
|
21-04-23
|
22-03-30
|
23-03-27
|
24-04-15
|
-
|
-
|
-
|
Last Close Price
15.41
CNY Average target price
13.96
CNY Spread / Average Target -9.38% Consensus |
1st Jan change
|
Capi.
|
---|
| -9.46% | 3.15B | | +37.08% | 5.92B | | -17.43% | 4.51B | | +0.51% | 3.1B | | -3.53% | 2.42B | | +41.15% | 1.97B | | -5.15% | 1.68B | | +0.09% | 1.65B | | -10.38% | 1.53B | | +36.02% | 1.38B |
Alternative Medicine
|